Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Fulcrum Therapeutics, Inc. (FULC) had Weighted-Average Shares Outstanding (Diluted) of 61.98M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$80.00M |
|
$-9.72M |
|
-- |
|
$80.00M |
|
$101.90M |
|
$-21.90M |
|
$12.17M |
|
$-9.72M |
|
$-9.72M |
|
$-9.72M |
|
$-9.72M |
|
$-9.72M |
|
$-9.72M |
|
$-21.90M |
|
$-20.30M |
|
61.98M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
61.98M |
$-0.16 |
|
$-0.16 |
|
| Balance Sheet Financials | |
$249.92M |
|
$3.90M |
|
$10.79M |
|
$260.72M |
|
$11.04M |
|
-- |
|
$6.64M |
|
$17.68M |
|
$243.03M |
|
$243.03M |
|
$243.03M |
|
53.97M |
|
| Cash Flow Statement Financials | |
$-2.22M |
|
$32.23M |
|
$2.75M |
|
$26.66M |
|
$59.41M |
|
$32.76M |
|
$14.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
22.63 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-27.37% |
|
-27.37% |
|
-25.38% |
|
-12.16% |
|
-12.16% |
|
$-2.50M |
|
-- |
|
-- |
|
-- |
|
0.31 |
|
-- |
|
38.17 |
|
9.56 |
|
-4.00% |
|
-4.00% |
|
-3.73% |
|
-4.00% |
|
$4.50 |
|
$-0.04 |
|
$-0.04 |
|